Vera Therapeutics Inc.

NASDAQ: VERA · Real-Time Price · USD
21.55
0.28 (1.32%)
At close: Aug 15, 2025, 3:59 PM
21.21
-1.58%
After-hours: Aug 15, 2025, 07:17 PM EDT

Vera Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-218.28M -175.46M -152.15M -134.38M -107.85M -94.3M -95.99M -102.77M -107.35M -102.04M -89.06M -73.46M -56.4M -44.98M -32.61M -58.64M -55.49M -55.65M
Depreciation & Amortization
283K 1.66M 622K -68K -1.53M -4M -3.55M -3.52M -2.23M -1.36M -846K -217K -6K 150K 176K -498K 116K 178K
Stock-Based Compensation
29.02M 24.42M 20.8M 17.81M 15.14M 12.95M 11.49M 11.02M 10.55M 9.89M 8.89M 7.1M 5.58M 4.27M 3.01M 2.19M 1.38M 674K
Other Working Capital
-8.9M -2.21M 6.11M 9.01M -850K -15.41M -6.03M -1.58M 1.96M 9.82M 3.08M 3.4M 5.45M 2.02M 3.04M -1.35M -2.97M 489K
Other Non-Cash Items
8.01M -805K 8.43M 12.86M 15.14M 12.38M 4.83M 2.28M 6.16M 6.14M 6.13M 10.41M 5.87M 5.16M 4M 15.07M 15.58M 16.14M
Deferred Income Tax
n/a n/a n/a -3.13M -3.12M -3.09M -3.09M 44K 29K n/a n/a 247K 611K -1.8M -1.8M -2.05M -1.23M 1.19M
Change in Working Capital
-5.9M 244K 2.66M 1.31M -9.47M -15.52M -5.87M 4.74M 9.19M 1.91M 6.75M 2.5M 3.86M 8.64M 3.51M -730K -1.97M 855K
Operating Cash Flow
-185.27M -155.25M -134.68M -120.64M -106.73M -99.72M -92.18M -88.2M -83.65M -84.91M -67.6M -52.87M -39.94M -28.57M -23.71M -44.65M -41.62M -36.63M
Capital Expenditures
-26.15M -1.16M -972K -390K 24.72M -63K -63K -6K -44K -50K -68K -62K -24K -18K n/a n/a n/a -47K
Cash Acquisitions
n/a n/a n/a -18.62K -18.62K -18.62K -18.62K n/a 2.4K 2.4K 2.4K 2.4K n/a 796K 796K 796K 796K n/a
Purchase of Investments
-554.21M -540.57M -703.01M -462.2M -417.93M -445.69M -224.93M -182.29M -194.02M -143.26M -148.49M -137.93M -97.52M -39.44M n/a n/a n/a n/a
Sales Maturities Of Investments
417.08M 349.52M 278.96M 277.5M 210.9M 174.8M 185.56M 137.74M 130.84M 124.44M 78M 54M 16M n/a n/a n/a n/a n/a
Other Investing Acitivies
24.07M 26.56M 24.56M 24.58M -273.44K -270.89K -39.37K -51.99K -70.62K -26.26K -77.93K -5.08M -5.08M -4.24M -4.2M 853K 853K 57K
Investing Cash Flow
-139.21M -190.43M -425.03M -185.09M -207.18M -270.95M -39.43M -44.55M -63.22M -18.86M -70.55M -88.99M -86.55M -43.66M -4.2M 853K 853K 10K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1K n/a -18K -50K 519K
Common Stock Repurchased
-13K -13K -13K -13K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -61 -61
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
22.57M 5.72M -6.81M 18.02M 17.57M 14.56M 18.54M 14.42M 15.03M 14.65M 15.8M 13K -894K -3.13M 2.71M 77.6M 77.54M 79.78M
Financial Cash Flow
348.51M 331.67M 606.67M 305.55M 305.1M 302.1M 133.54M 129.42M 130.03M 129.65M 101.93M 86.14M 85.24M 134.18M 53.88M 128.76M 128.67M 80.3M
Net Cash Flow
24.04M -14.02M 46.97M -185K -8.8M -68.57M 1.93M -3.33M -16.83M 25.88M -36.22M -55.72M -41.25M 61.95M 25.97M 84.96M 87.91M 43.68M
Free Cash Flow
-211.42M -156.41M -135.65M -121.03M -82.01M -99.78M -92.24M -88.2M -83.69M -84.96M -67.66M -52.93M -39.96M -28.59M -23.71M -44.65M -41.62M -36.67M